Patents by Inventor Andre Malanda

Andre Malanda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8735432
    Abstract: The invention concerns compounds of general formula (I), wherein n, X1, X2, X3, X4, Y and W are as defined herein. The invention also concerns a method for preparing said compounds and their therapeutic use.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: May 27, 2014
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda
  • Patent number: 8716272
    Abstract: The invention relates to compounds of the general formula (I): Wherein X, Y, Z, Z1, Z2, Z3, Z4 and n are as defined herein. The invention also relates to a method for making the same and to the use thereof in therapy.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: May 6, 2014
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Catherine Gille, David Machnik, Andre Malanda
  • Patent number: 8716273
    Abstract: The invention relates to compounds of the general formula (I): Wherein X, Y, Z, Z1, Z2, Z3, Z4 and n are as defined herein. The invention also relates to a method for making the same and to the use thereof in therapy.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: May 6, 2014
    Assignee: SANOFI
    Inventors: Laurent Dubois, Yannick Evanno, Catherine Gille, David Machnik, Andre Malanda
  • Patent number: 8604050
    Abstract: The disclosure relates to compounds of formula (I): wherein X1, X2, X3, X4, Y, n, A, and W are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: December 10, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Catherine Gille, Andre Malanda
  • Patent number: 8586573
    Abstract: The invention concerns compounds of general formula (I): Wherein n, X1, X2, X3, X4, Y, Z, Z1, Z2, Z3 and Z4 are as defined herein. The invention also concerns a process for the preparation of compounds of formula (I) and their therapeutic use.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: November 19, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda, David Machnik, Catherine Gille
  • Patent number: 8507520
    Abstract: Compounds of formula (I): wherein R, R1, R2, R3, R4, and X are as defined in the disclosure, or an acid addition salt thereof, and the therapeutic use and process of synthesis thereof.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: August 13, 2013
    Assignee: Sanofi
    Inventors: Danielle De Peretti, Yannick Evanno, Patrick Lardenois, Nathalie Rakotoarisoa, Antonio Almario Garcia, André Malanda
  • Patent number: 8481745
    Abstract: The invention relates to compounds of general formula (I): Wherein n, X1, X2, X3, X4, Y, Z1, Z2, Z3, Z4, Ra and Rb are as defined herein. The invention also relates to process for the preparation of compounds of formula (I) and their therapeutic use.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: July 9, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda
  • Patent number: 8420817
    Abstract: The invention relates to tricyclic N-heteroaryl-carboxamide derivatives having the formula (I): Wherein A, P, W, Z1, Z2, Z3, Z4, Z5, Z6, Z7, Z8, R3 and R3? are as described herein. The invention also relates to a method for preparing the same and to the therapeutic use thereof.
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: April 16, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda
  • Patent number: 8399491
    Abstract: This disclosure relates to compounds of formula (I): wherein G1, G2, G3, G4, n, Y, Z, Z1, Z2, Z3, and Z4 are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: March 19, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, André Malanda
  • Patent number: 8394820
    Abstract: This disclosure relates to compounds of formula (I): wherein X1, X2, X3, X4, n, Y, W, and A are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: March 12, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, André Malanda, Odile LeClerc
  • Publication number: 20130046095
    Abstract: The invention concerns compounds of general formula (I), wherein n, X1, X2, X3, X4, Y and W are as defined herein. The invention also concerns a method for preparing said compounds and their therapeutic use.
    Type: Application
    Filed: October 23, 2012
    Publication date: February 21, 2013
    Inventors: Laurent DUBOIS, Yannick EVANNO, Andre MALANDA
  • Patent number: 8354425
    Abstract: The disclosure relates to compounds of formula (I): wherein X1, X2, X3, X4, Z1, Z2, Z3, Z4, Ra, Rb, n, Y, and W are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: January 15, 2013
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, David Machnik, André Malanda
  • Patent number: 8318775
    Abstract: The invention concerns compounds of general formula (I), wherein n, X1, X2, X3, X4, Y and W are as defined herein. The invention also concerns a method for preparing said compounds and their therapeutic use.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: November 27, 2012
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda
  • Patent number: 8299114
    Abstract: The disclosure relates to compounds of formula (I): wherein X1, X2, X3, X4, Y, n, A, and W are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: October 30, 2012
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Catherine Gille, André Malanda
  • Publication number: 20120264944
    Abstract: The invention relates to compounds of general formula (I): Wherein n, X1, X2, X3, X4, Y, Z1, Z2, Z3, Z4, Ra and Rb are as defined herein. The invention also relates to process for the preparation of compounds of formula (I) and their therapeutic use.
    Type: Application
    Filed: June 22, 2012
    Publication date: October 18, 2012
    Applicant: SANOFI
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda
  • Patent number: 8288376
    Abstract: The invention concerns tricyclic N-heteroaryl-carboxamide derivatives containing a benzimidazole unit of general formula (I): Wherein A, P, Y, R1, R2 and R3 are as defined herein. The invention also concerns a method of preparing the compounds and their therapeutic use.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: October 16, 2012
    Assignee: Sanofi
    Inventors: Laurent Dubois, Yannick Evanno, Luc Even, Catherine Gille, Andre Malanda, David Machnik, Nathalie Rakotoarisoa
  • Publication number: 20120252837
    Abstract: The disclosure relates to compounds of formula (I): wherein X1, X2, X3, X4, Y, n, A, and W are as defined in the disclosure, or a salt thereof, or a hydrate or solvate thereof, and to processes for the preparation of these compounds and the therapeutic use thereof.
    Type: Application
    Filed: May 8, 2012
    Publication date: October 4, 2012
    Applicant: SANOFI
    Inventors: Laurent Dubois, Yannick Evanno, Catherine Gille, André Malanda
  • Patent number: 8227489
    Abstract: The invention relates to compounds of general formula (I): Wherein n, X1, X2, X3, X4, Y, Z1, Z2, Z3, Z4, Ra and Rb are as defined herein. The invention also relates to process for the preparation of compounds of formula (I) and their therapeutic use.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: July 24, 2012
    Assignee: Sanofi-Aventis
    Inventors: Laurent Dubois, Yannick Evanno, Andre Malanda
  • Publication number: 20120165531
    Abstract: The invention relates to tricyclic N-heteroaryl-carboxamide derivatives having the formula (I): Wherein A, P, W, Z1, Z2, Z3, Z4, Z5, Z6, Z7, Z8, R3 and R3? are as described herein. The invention also relates to a method for preparing the same and to the therapeutic use thereof.
    Type: Application
    Filed: March 6, 2012
    Publication date: June 28, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Laurent DUBOIS, Yannick EVANNO, Andre MALANDA
  • Publication number: 20120142670
    Abstract: The invention relates to compounds of the general formula (I): Wherein X, Y, Z, Z1, Z2, Z3, Z4 and n are as defined herein. The invention also relates to a method for making the same and to the use thereof in therapy.
    Type: Application
    Filed: February 10, 2012
    Publication date: June 7, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Laurent Dubois, Yannick Evanno, Catherine Gille, David Machnik, André Malanda